Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

HIV Infections × Lopinavir × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Uterine Cervical Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Small Cell Lung Carcinoma 1 Sarcoma, Kaposi 1 Respiratory Distress Syndrome 1 Prostatic Neoplasms 1 Pneumonia, Viral 1 Oligodendroglioma 1 Melanoma 1 Hodgkin Disease 1 High-Grade Anal Intraepithelial Neoplasia 1 Hematologic Neoplasms 1 HIV Infections 1 Gliosarcoma 1 Glioma 1 Glioblastoma 1 Esophageal Squamous Cell Carcinoma 1 Ependymoma 1 Cytokine Release Syndrome 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Hepatocellular 1 Brain Neoplasms 1 Astrocytoma 1 Acquired Immunodeficiency Syndrome 1

Interventions

Doxorubicin 19 Vincristine 16 Cyclophosphamide 12 Zidovudine 11 Bleomycin 11 Etoposide 10 Rituximab 6 Interferon alpha-2 6 Cytarabine 6 Prednisone 5 Polymerase Chain Reaction 5 Liposomes 5 Dexamethasone 5 Biopsy 5 sargramostim 4 Specimen Handling 4 Methotrexate 4 Magnetic Resonance Spectroscopy 4 Leucovorin 4 Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 4 Fluorouracil 4 Filgrastim 4 tecogalan 3 Peripheral Blood Stem Cell Transplantation 3 Paclitaxel 3 Nivolumab 3 Carmustine 3 interferon alfa-n1 2 fludarabine 2 cabozantinib 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00444379 2014-08-20

ARKS

University of California, San Francisco

Phase 4 Completed

Acquired Immunodeficiency Syndrome, Sarcoma, Kaposi, HIV Infections

Data powered by HemOnc (CC BY 4.0) Colophon ⚡